Patent directory · USPTO A61K / A61P
Patents matching “Sarepta Therapeutics, Inc.”
102 pharma patents match "Sarepta Therapeutics, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 102 pharmaceutical patents matching "Sarepta Therapeutics, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 12377150
Exon skipping oligomer conjugates for muscular dystrophy
granted -
US 12370261
Chimeric peptides for antisense delivery
granted -
US 12286630
Treatment methods for muscular dystrophy
granted -
US 12239715
Peptide oligonucleotide conjugates
granted -
US 12168059
Trimeric peptides for antisense delivery
granted -
US 12139709
Antisense oligomers and methods of using the same for treating diseases associated with the acid alpha-glucosidase gene
granted -
US 12138312
Cell-penetrating peptides for antisense delivery
granted -
US 12121532
Modified antisense oligomers for exon inclusion in spinal muscular atrophy
granted -
US 12104163
Adeno-associated virus vectors for treatment of Rett syndrome
granted -
US 11932851
Exon skipping compositions for treating muscular dystrophy
granted -
US 11925675
Systemic delivery of adeno-associated virus vector expressing gamma-sarcoglycan and the treatment of muscular dystrophy
granted -
US 11911403
Antisense-induced exon exclusion in type VII collagen
granted -
US 11732259
Peptide oligonucleotide conjugates
granted -
US 11674139
Oligonucleotides for treating expanded repeat diseases
granted -
US 11672871
Peptide oligonucleotide conjugates
granted -
US 11642364
Exon skipping oligomer conjugates for muscular dystrophy
granted -
US 11555189
Antisense oligomer compounds
granted -
US 11491238
Exon skipping oligomer conjugates for muscular dystrophy
granted -
US 11395855
Exon skipping oligomer conjugates for muscular dystrophy
granted -
US 11382981
Exon skipping oligomer conjugates for muscular dystrophy
granted -
US 11338041
Exon skipping oligomer conjugates for muscular dystrophy
granted -
US 11236329
Compound and method for treating myotonic dystrophy
granted -
US 11236338
Antisense-induced exon2 inclusion in acid alpha-glucosidase
granted -
US 11225662
Peptide oligonucleotide conjugates
granted